Programme at a glance

Programme at a glance, Barcelona

Thursday, 2 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
15.00 - 18.40
West meets East: Current practices and policies in the management of musculoskeletal aging - Meeting jointly organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Chinese Society of Osteoporosis and Bone Mineral Research (CSOBMR), under the auspices of the International Osteoporosis Foundation (IOF), the WHO World Health Organization Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Ageing, the Sociedad Española de Investigación Ósea y Metabolismo Mineral (SEIOMM) and the Chinese Medical Association (CMA).
‣ 15.00 - Opening Weibo Xia and Jean‑Yves Reginster
‣ 15.10 - Importance of musculoskeletal health and aging for the WHO: perspectives in Europe and in China Islene Araujo de Carvalho (WHO)
‣ 15.25 - Regulatory requirements for the registration of drugs to be used in osteoporosis and osteoarthritis: the Chinese view point Zhimin Yang (PRC‑FDA)
‣ 15.40 - Regulatory requirements for the registration of drugs to be used in osteoporosis and osteoarthritis: the European view point Andrea Laslop (EMA)
15.55
Osteoarthritis
Chairpersons: ‣ Zhenling Zhang, ‣ Cyrus Cooper
15.55
Revised 2019 ESCEO algorithm for the management of knee osteoarthritis
‣ Olivier Bruyère
16.10
Chinese guidelines for the management of osteoarthritis
‣ Jianhao Lin
16.25
SYSADOAs and nutriceuticals for the management of osteoarthritis: the European viewpoint
‣ Jean‑Yves Reginster
16.40
SYSADOAs and nutriceuticals for the management of osteoarthritis: the Chinese viewpoint
‣ Zhiyi Zhang
16.55
Discussion
17.05
Courtesy Break
17.20
Osteoporosis
Chairperson: ‣ Weibo Xia and René Rizzoli
17.20
Update of the Chinese guidelines for the management of post-menopausal osteoporosis
‣ Mei Li
17.35
ESCEO-IOF algorithm for the management of patients at low/high/very high risk of fractures
‣ John A. Kanis
17.50
New therapeutic regimens to fill the gap in the treatment of osteoporosis
‣ René Rizzoli
18.05
Role of the Chinese Traditional Medicines for the management of osteoporosis
‣ Lin Shen
18.20
Discussion
18.30
Conclusion
‣ Zhenlin Zhang and Jean‑Yves Reginster
18.40
Closure of the meeting
19.00 - 20.40
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: ‣ John A. Kanis, ‣ Jean‑Yves Reginster
19.00
Best clinical papers published in 2019
‣ René Rizzoli
19.45
ESCEO-IOF algorithm for the management of patients at low/high/very high risk of fracture
‣ John A. Kanis
20.00
Opening of the meeting
‣ Cyrus Cooper
20.20
Launch of the WHO package of tools on Integrated Care for Older People (ICOPE)
‣ Islene Araujo de Carvalho (World Health Organization – Geneva)
20.25
Presentation of the 2020 ESCEO Medal of Excellence
‣ Jean‑Yves Reginster
20.30
Presentation of the IOF Olof Johnell Science Award
‣ Cyrus Cooper
20.35
Ten years of experience in fighting osteoporosis with the ESCEO-IOF Song powered by Johann Sebastian Bach
‣ Christian Guenther
Friday, 3 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
Gut microbiota (GMB) and osteoarthritis (OA) management: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing.
Chairpersons: ‣ Islene Araujo de Carvalho, ‣ Sansin Tüzün, ‣ Francis Berenbaum
‣ Introduction Emmanuel Biver
‣ Gut microbiota and inflammation Claudio Franceschi
‣ Role of gut microbiota in non-communicable disease and osteoarthritis management Emmanuel Biver
‣ Discussion Francis Berenbaum
Panel: ‣ Islene Araujo de Carvalho, ‣ Francis Berenbaum, ‣ Emmanuel Biver, ‣ Maria Luisa Brandi, ‣ Philip Calder, ‣ Vincenzo Castronovo, ‣ Etienne Cavalier, ‣ Antonio Cherubini, ‣ Elaine M. Dennison, ‣ Claudio Franceschi, ‣ Nicholas R. Fuggle, ‣ Pierre Miossec, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Thierry Thomas, ‣ Sansin Tüzün, ‣ Nicola Veronese
09.00 - 10.30
SCIENTIFIC SESSION I
Chairpersons: ‣ Cyrus Cooper, ‣ René Rizzoli
09.00
Plenary Lecture 1
‣ Transient treatment discontinuation : pros and cons Michael R. McClung
09.30
Oral communication selected from abstracts
10.30 - 12.10
SCIENTIFIC SESSION II
Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis
10.30
Presentation of the ESCEO-IOF Herbert Fleisch Medal
‣ René Rizzoli
10.35
Presentation of the IOF President's Award
‣ Cyrus Cooper
10.40
Plenary Lecture 2
‣ Differences in clinical guidelines Eugene McCloskey
11.10
Oral communication selected from abstracts
14.00 - 15.00
Poster Viewing Session I
14.00 - 15.00
Oral presentation of selected posters
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Discussion of complex osteoporotic cases
‣ Adolfo Diez‑Perez
Management of CKD-MBD
‣ Jorge Cannata Andia
Nutritional approach of osteoporosis prevention
‣ Stefania Maggi
GIOP : what to do ?
‣ Emmanuel Biver
Pharmacoepidemiology of musculoskeletal disease
‣ Daniel Prieto‑Alhambra
14.00 - 15.00
Alternative treatments for osteoarthritis: stem cells, platelet-rich plasma, autologous chondrocyte transplantation, ...: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Willem Lems, ‣ Francis Berenbaum
‣ Introduction and scope of the problem Emmanuel Maheu
‣ Role of surgical regenerative therapies in the management of knee osteoarthritis Richard Oreffo
‣ Role of "alternative" treatments of knee osteoarthritis Nicholas R. Fuggle
‣ Discussion Jean‑François Kaux
Panel: ‣ Francis Berenbaum, ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Philip Conaghan, ‣ Cyrus Cooper, ‣ Bernard Cortet, ‣ Maurizio Cutolo, ‣ Nicholas R. Fuggle, ‣ Germain Honvo, ‣ Jean‑François Kaux, ‣ Andrea Laslop, ‣ Willem Lems, ‣ Emmanuel Maheu, ‣ Radmila Matijevic, ‣ Richard Oreffo, ‣ Andrew Price, ‣ Jean‑Yves Reginster, ‣ Roland Roth, ‣ Thierry Thomas, ‣ Nicola Veronese
14.00 - 15.00
Is there a role for MHT in the management of post-menopausal osteoporosis? Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Maria Luisa Brandi, ‣ Tim Hillard
‣ Welcome and scope of the problem Antonio Cano
‣ Effects of MHT on bone: What, when, how? Florence Trémollières
‣ Risk/benefit ratio of MHT before and after 60 years Giuseppe Rosano
‣ Discussion (Leader: Serge Rozenberg): All participants of the Working Group
‣ Conclusions Antonio Cano
Panel: ‣ Mylène Aubertin‑Leheudre, ‣ Maria Luisa Brandi, ‣ Antonio Cano, ‣ Peter Collins, ‣ Cyrus Cooper, ‣ Andrea Genazzani, ‣ Nicholas Harvey, ‣ Tim Hillard, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Irene Lambrinoudaki, ‣ Andrea Laslop, ‣ Daniel Prieto‑Alhambra, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Giuseppe Rosano, ‣ Serge Rozenberg, ‣ Florence Trémollières
15.00 - 17.00
SCIENTIFIC SESSION III
Chairpersons: ‣ Nicholas Harvey, ‣ Bess Dawson‑Hughes
15.00
Plenary Lecture 3
‣ Bone turnover markers in clinical practice Etienne Cavalier
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 4
‣ Bone fragility: beyond bone loss Serge Ferrari
15.00 - 16.45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Musculoskeletal diseases: diagnosis, management and consequences
Chairpersons: ‣ Philippe Halbout, ‣ Jean‑Yves Reginster, ‣ Famida Jiwa
15.45
Presentation of the IOF Committee of National Societies Medal
‣ Jean‑Yves Reginster
Saturday, 4 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
Radiofrequency Echographic Multi-Spectrometry for the in-Vivo Assessment of Bone Strength: State of the Art: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Maria Luisa Brandi, ‣ Adolfo Diez‑Perez
‣ Introduction Hans Peter Dimai
‣ Current role of bone strength in the assessment of fracture risk Thierry Thomas
‣ Radiofrequency echographic multi-spectrometry: Basic principles and clinical validation Maria Luisa Brandi
‣ Discussion Stefano Gonnelli
Panel: ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Sergio Casciaro, ‣ Loredana Cavalli, ‣ Bernard Cortet, ‣ Adolfo Diez‑Perez, ‣ Hans Peter Dimai, ‣ Stefano Gonnelli, ‣ Philippe Halbout, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Médéa Locquet, ‣ Radmila Matijevic, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Thierry Thomas
08.00 - 09.00
Impact of whole dairy matrix on musculoskeletal health and aging. Outcomes of a workshop organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairperson: ‣ Arne Astrup
‣ Introduction Arne Astrup
‣ The concept of food matrix compared to single nutrients Ian Givens
‣ Importance of dairy matrix for skeletal health Sandra Iuliano
‣ Discussion Yannis Manios
‣ Conclusion and wrap up Arne Astrup
Panel: ‣ Arne Astrup, ‣ Nina Geiker, ‣ Ian Givens, ‣ Sandra Iuliano, ‣ Jean‑Michel Lecerf, ‣ Yannis Manios, ‣ Christian Molgaard, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Luc J. C. van Loon
08.00 - 09.00
EUGMS-ESCEO-IOF Joint Session "Avoiding medication related harm when treating osteoarticular disease in older people"
Chairperson: ‣ Finbarr Martin
‣ Introduction: Medication related harm Finbarr Martin
‣ Drugs that may harm your older patients: potentially inappropriate prescribing Mirko Petrovic
‣ Potential problems in the use of drugs for osteoarticular conditions in old age Antonio Cherubini
09.00 - 10.30
SCIENTIFIC SESSION IV
Chairpersons: ‣ Elaine M. Dennison, ‣ Olivier Bruyère
09.00
Plenary Lecture 5
‣ Sarcopenia : new definitions and clinical implications Alfonso Cruz Jentoft
09.30
Oral communication selected from abstracts
10.20
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
‣ John A. Kanis
10.30 - 12.00
SCIENTIFIC SESSION V
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Manju Chandran
10.30
Presentation of the IOF Medal of Achievement
‣ Nicholas Harvey
10.40
Plenary Lecture 6
‣ How to reduce falls in oldest people ? Heike A. Bischoff‑Ferrari
11.10
Oral communication selected from abstracts
14.00 - 15.00
Poster Viewing Session II
14.00 - 15.00
Oral presentation of selected posters
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Menopausal hormone therapy in 2020
‣ Santiago Palacios
Risks and benefits of calcium supplementation
‣ Nicholas Harvey
Physical therapy for osteoarthritis
‣ Olivier Bruyère
Local bone treatments
‣ Maria Luisa Brandi
Milk, yogurt, cheese and bone: Friends or foes ?
‣ Sandra Iuliano
Structural determinants and purity differ in food supplement respect to CS based pharma products: effect on biological features (supported by an Unrestricted Educational Grant from Ibsa)
‣ Chiara Schiraldi
14.00 - 15.00
Algorithm for the use of biochemical markers of bone turnover in the diagnosis and follow-up of treatment for osteoporosis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing
Chairpersons: ‣ Etienne Cavalier, ‣ Adolfo Diez‑Perez
‣ Introduction John A. Kanis
‣ Clinical application of bone turnover markers in post-menopausal osteoporosis Mattias Lorentzon
‣ Algorithm for the assessment of anti-osteoporosis treatments by bone turnover markers Eugene McCloskey
‣ Discussion Markus Herrmann
Panel: ‣ Jaime Branco, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Etienne Cavalier, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Bernard Cortet, ‣ Adolfo Diez‑Perez, ‣ Serge Ferrari, ‣ Andrea Ildiko Gasparik, ‣ Markus Herrmann, ‣ Niklas Rye Jorgensen, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Andrea Laslop, ‣ Médéa Locquet, ‣ Mattias Lorentzon, ‣ Radmila Matijevic, ‣ Eugene McCloskey, ‣ Salvatore Minisola, ‣ Richard Pikner, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Pawel Szulc
15.00 - 17.00
SCIENTIFIC SESSION VI
Chairpersons: ‣ Charlotte Beaudart, ‣ E. M. Curtis
15.00
Plenary Lecture 7
‣ What did we learn from the recent large vitamin D trials Bess Dawson‑Hughes
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 8
‣ New pharmacological treatments for osteoarthritis Elaine M. Dennison
15.00 - 16.45
Committee of Scientific Advisors Special Session: Technology, comorbidity and rehabilitation in bone health- highlights from the IOF Committee of Scientific Advisors 2020
Chairpersons: ‣ Nicholas Harvey, ‣ Serge Ferrari
‣ Novel technologies for the non-invasive evaluation of femoral strength in fracture risk assessment Mary Bouxsein
‣ Optimisation of bone health in chronic kidney disease: EUROD-IOF consensus statement Kassim Javaid
‣ Maximising function through post-fracture rehabilitation Olivier Bruyère
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
Sunday, 5 April 2020
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
ESPRM-ESCEO-IOF Joint Session
Fibromyalgia : An evidence-based approach for diagnosis and management
Chairperson: ‣ Fitnat Dincer
‣ Update in Diagnosis of Fibromyalgia on the basis of Evidence Based Medicine Andreas Winkelman
‣ Update in Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Fitnat Dincer
‣ Update in Non-Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Raquel Valero, Susana Munoz
08.00 - 09.00
Educational Lecture
‣ Management of hyperparathyroidism in chronic kidney disease
‣ Pierre Delanaye
08.00 - 09.00
SICOT-ESCEO-IOF Symposium: Fracture Liaison Services (FLS) in Orthopaedic Surgery
Chairpersons: ‣ Josée Delisle, ‣ Philippe Halbout
‣ Opening message Philippe Halbout, Josée Delisle
‣ Success story of collaboration between orthopaedics and rest of the world in FLS! How can I work with my orthopaedic surgeon? Julio Fernandes
‣ Getting FLSs sustainable - key steps Kassim Javaid
‣ Teams and empowerment! How to create synergy between the Nurse, Doctor, Family and the Patient? Josée Delisle
‣ Crossfire and Q&A
‣ Closing message Josée Delisle
08.00 - 09.00
Assessment of cardio-vascular safety of anti-osteoporosis medications. Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Nicholas R. Fuggle
‣ Welcome and scope of the problem Adolfo Diez‑Perez
‣ Assessment of cardio-vascular safety of Calcium and Vitamin D Nicholas Harvey
‣ Assessment of cardio-vascular safety of menopausal hormonal therapy and SERMs Santiago Palacios
‣ Assessment of cardio-vascular safety of peptides and monoclonal antibodies used as a treatment for osteoporosis René Rizzoli
‣ Discussion (Leader: Santiago Palacios): All participants of the Working Group
‣ Conclusions Nicholas R. Fuggle
Panel: ‣ Maria Luisa Brandi, ‣ Antonio Cano, ‣ Cyrus Cooper, ‣ Elaine M. Dennison, ‣ Adolfo Diez‑Perez, ‣ Nicholas R. Fuggle, ‣ Nicholas Harvey, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Santiago Palacios, ‣ Daniel Prieto‑Alhambra, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Serge Rozenberg, ‣ Thierry Thomas, ‣ Florence Trémollières
09.00 - 10.00
Poster Viewing Session III
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Bone and joints in intense competition sport : lesson for the practice ?
‣ Jean‑François Kaux
Bariatric surgery, bone and joints
‣ Daniel Prieto‑Alhambra
Androgens, bone and muscles
‣ Jean‑Marc Kaufman
Efficacy and cost/benefit of FLS
‣ Radmila Matijevic
High Bone Mass: What are the causes and how should we manage it?
‣ Celia L. Gregson
Local Bone Treatment in Osteoporosis (supported by an Unrestricted Educational Grant from Agnovos Healthcare)
‣ Andreas Kurth
10.00 - 12.00
SCIENTIFIC SESSION VII
Chairpersons: ‣ Famida Jiwa, ‣ Serge Ferrari
10.00
Plenary Lecture 9
‣ Rare bone diseases : what do they teach us for musculoskeletal disorders management Kassim Javaid
10.30
Presentation of the ESCEO-IOF Young Investigator Awards
‣ Cyrus Cooper
10.40
Oral communication selected from abstracts
11.30
Plenary Lecture 10
‣ Strategies to fill the Treatment Gap in Osteoporosis: place of Combination and Sequential Regimens Manju Chandran
12.00 - 13.00
NON-SPONSORED SYMPOSIA